The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Greninger, D A

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile. [electronic resource] - Haemophilia : the official journal of the World Federation of Hemophilia Mar 2008 - 295-302 p. digital

Publication Type: Comparative Study; Journal Article

1365-2516

10.1111/j.1365-2516.2007.01620.x doi


Adolescent
Adult
Autoantibodies--blood
B-Lymphocytes--immunology
Child
Child, Preschool
Drug Combinations
Epitope Mapping
Epitopes--analysis
Factor VIII--immunology
Genotype
Hemophilia A--drug therapy
Hemostatics--therapeutic use
Humans
Immune Tolerance
Infant
Infant, Newborn
Retrospective Studies
Treatment Outcome
von Willebrand Factor--therapeutic use